Sam Altman on OpenAI's closed-source approach

Sam Altman: OpenAI has been on the ‘wrong side of history’ concerning open source
In a Reddit AMA, OpenAI CEO Sam Altman said that he believes OpenAI has been 'on the wrong side of history' concerning its open source approach.
OpenAI CEO Sam Altman Has a Billion-Dollar Net Worth. Here's How He Got There
OpenAI CEO Sam Altman is a billionaire, thanks to his investments in technology companies like Reddit, Stripe, Airbnb, and more. Here's how Altman made his money.
Sam Altman admits OpenAI was ‘on the wrong side of history’ in open source debate
Sam Altman, CEO of OpenAI, admits the company was "on the wrong side of history" in the open source AI debate during a Reddit AMA, signaling a potential strategy shift as Chinese competitor DeepSeek disrupts the market with efficient,
Sam Altman’s ousting from OpenAI has entered the cultural zeitgeist
The lights dimmed as five actors took their places around a table on a makeshift stage in a New York City art gallery turned theater for the night. Wine
Sam Altman says OpenAI will embrace two new AI approaches, one from DeepSeek and another from Meta
During a Reddit AMA on Friday, Altman said OpenAI has "been on the wrong side of history" when it comes to keeping model weights confidential.
Sam Altman’s Answer to DeepSeek Is Giving Away OpenAI’s Tech
CEO of the ChatGPT maker says his company has been “on the wrong side of history” with open-source software.
Sam Altman Discusses DeepSeek and its Impact on OpenAI
Altman admitted that OpenAI was "on the wrong side of history" when it came to AI and open source and said he wants to fix that.
OpenAI founder Altman to visit Korea for AI event, meeting with biz leaders
Sam Altman, founder and chief executive officer (CEO) of U.S. artificial intelligence (AI) company OpenAI, will visit Korea ...
Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
ENDPOINTS NEWS9d
With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
decrypt13d
OpenAI's Altman Slams Brakes on o3 Hype After Weeks of Teasing AGI Breakthrough
"Cut your expectations by 100x," says Sam Altman, who also recently predicted superintelligence was just "a few thousand days ...